AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Imagion Biosystems

0.010

-0.001-9.09%

Volume:1.24M

Turnover:13.27K

Market Cap:8.01M

PE:-0.64

High:0.011

Open:0.010

Low:0.010

Close:0.011

52wk High:0.055

52wk Low:0.010

Shares:801.01M

Float Shares:172.45M

Volume Ratio:0.85

T/O Rate:0.72%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.016

EPS(LYR):-0.016

ROE:-2804.87%

ROA:-319.68%

PB:-2.34

PE(LYR):-0.64

Loading ...

Overview Company News Filings

Imagion Biosystems Ltd-imagion Extends Collaboration with Siemens Healthineers

THOMSON REUTERS

Imagion Biosystems Secures Au$3.75m in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial

THOMSON REUTERS

Australia's Imagion Biosystems Falls on Discounted Placement

Imagion Biosystems Ltd - Issue Price for Placement A$0.012 Per New Share

THOMSON REUTERS

Imagion Biosystems - Secures A$3.75 Mln in Firm Commitments Under Capital Raising

THOMSON REUTERS

BRIEF-Imagion Biosystems Seeks Trading Halt

Imagion Biosystems - Trading Halt Requested Pending Capital Raise Announcement

THOMSON REUTERS

Imagion Biosystems says FDA clears MagSense Phase 1b/2 breast cancer trial IND

BUZZ-Australia's Imagion Biosystems surges on US regulatory win for imaging agent

Imagion Biosystems - Receives FDA Ind Clearance for Magsense Her2 Imaging Agent

THOMSON REUTERS

BRIEF-Imagion Biosystems Receives A$300,000 Additional Funding Under Mercer Street Agreement

Imagion Biosystems Submits IND Application to FDA for MagSense HER2 Imaging Agent

Medical-Imaging Company Imagion Biosystems Lodges Ind With FDA for Phase 2 Trial of Magsense® Her2 Targeted Imaging Agent

THOMSON REUTERS

Imagion Biosystems Ltd - Enrollment for Phase 2 Trial Could Begin Q1 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/IBX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","market":"AU","secType":"STK","nameCN":"Imagion Biosystems","latestPrice":0.01,"timestamp":1787638320000,"preClose":0.011,"halted":0,"volume":1238223,"delay":0,"changeRate":-0.09090909090909084,"nameEN":"Imagion Biosystems","floatShares":172453894,"shares":801006908,"eps":-0.01553,"marketStatus":"Not Yet Opened","change":-0.001,"latestTime":"08-25 16:12:00 AEST","open":0.01,"high":0.011,"low":0.01,"amount":13272,"amplitude":0.090909,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.01553,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.011,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.8463332822743427,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IBX.AU","preClose":0.011,"auctionPrice":0.01,"auctionVolume":99999,"auction":3,"marketStatus":"盘后竞价","timestamp":1787638005612}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","floatShares":172453894,"roa":"-319.68%","roe":"-2804.87%","lyrEps":-0.01553,"volumeRatio":0.8463332822743427,"shares":801006908,"dividePrice":0,"high":0.011,"amplitude":0.090909,"preClose":0.011,"low":0.01,"week52Low":0.01,"pbRate":"-2.34","psRate":"13.97","week52High":0.055,"institutionHeld":0,"latestPrice":0.01,"eps":-0.01553,"divideRate":0,"volume":1238223,"delay":0,"ttmEps":-0.01553,"open":0.01,"prevYearClose":0.025,"prevWeekClose":0.01,"prevMonthClose":0.012,"prevQuarterClose":0.011,"fiveDayClose":0.011,"twentyDayClose":0.012,"sixtyDayClose":0.017,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-11-16","symbol":"IBX.AU","defaultRemindTime":1700089200000,"type":"split","dateTimestamp":1700053200000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649727376","title":"Imagion Biosystems Ltd-imagion Extends Collaboration with Siemens Healthineers","url":"https://stock-news.laohu8.com/highlight/detail?id=2649727376","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649727376?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:39","pubTimestamp":1783381169,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUE4LYY2D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IBX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646804297","title":"Imagion Biosystems Secures Au$3.75m in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2646804297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646804297?lang=en_us&edition=fundamental","pubTime":"2026-06-25 23:52","pubTimestamp":1782402720,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUA1BWQ8J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBX.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646284707","title":"Australia's Imagion Biosystems Falls on Discounted Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2646284707","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646284707?lang=en_us&edition=fundamental","pubTime":"2026-06-25 09:08","pubTimestamp":1782349710,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Imagion Biosystems falls on discounted placement** Shares of Imagion BiosystemsIBX.AXfall as much as 13.3% to A$0.013, hitting their lowest level since May 26** Stock posts its weakes","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4N42X016:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBX.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646770844","title":"Imagion Biosystems Ltd - Issue Price for Placement A$0.012 Per New Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2646770844","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646770844?lang=en_us&edition=fundamental","pubTime":"2026-06-25 07:29","pubTimestamp":1782343752,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nFWN42W10R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBX.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646447088","title":"Imagion Biosystems - Secures A$3.75 Mln in Firm Commitments Under Capital Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2646447088","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646447088?lang=en_us&edition=fundamental","pubTime":"2026-06-25 07:29","pubTimestamp":1782343752,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nFWN42W10R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBX.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645005181","title":"BRIEF-Imagion Biosystems Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2645005181","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645005181?lang=en_us&edition=fundamental","pubTime":"2026-06-23 07:34","pubTimestamp":1782171241,"startTime":"0","endTime":"0","summary":"BRIEF-Imagion Biosystems Seeks Trading HaltJune 23 (Reuters) - Imagion Biosystems Ltd IBX.AX:TRADING HALT REQUESTED PENDING CAPITAL RAISE ANNOUNCEMENTFurther company coverage: IBX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42U0FR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","IBX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645005186","title":"Imagion Biosystems - Trading Halt Requested Pending Capital Raise Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2645005186","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645005186?lang=en_us&edition=fundamental","pubTime":"2026-06-23 07:33","pubTimestamp":1782171202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42U0FR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IBX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640794127","title":"Imagion Biosystems says FDA clears MagSense Phase 1b/2 breast cancer trial IND","url":"https://stock-news.laohu8.com/highlight/detail?id=2640794127","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640794127?lang=en_us&edition=fundamental","pubTime":"2026-06-02 23:10","pubTimestamp":1780413043,"startTime":"0","endTime":"0","summary":"Imagion Biosystems received an FDA “Study May Proceed” letter for its IND covering a Phase 1b/2 MagSense clinical trial in HER2+ breast cancer.The trial is set to confirm safety in Phase 1b, then assess detection of nodal metastases in Phase 2.City of Hope Cancer Center’s Mohammad Eghtedari will serve as principal investigator.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL9GNz56:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","IBX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640799498","title":"BUZZ-Australia's Imagion Biosystems surges on US regulatory win for imaging agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2640799498","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640799498?lang=en_us&edition=fundamental","pubTime":"2026-06-02 12:37","pubTimestamp":1780375063,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Imagion Biosystems surges on US regulatory win for imaging agent** Shares of Imagion Biosystems IBX.AX rise as much as 52.9% to A$0.026, their highest since February 27** Stock logs the largest intraday pct jump since early September 2025** Medical imaging firm receives notice from the U.S. Food and Drug Administration for clearing the Investigational New Drug  application for co's MagSense HER2 imaging agent** MagSense technology is a class of MRI imaging agents that improves cancer detection** Says FDA's allowance to proceed with the Phase 1b/2 clinical study in HER2+ breast cancer patients indicates that co comprehensively addressed all necessary logistical, analytical, quality and safety prerequisites** More than 42.3 million shares change hands, 19.2 times the 30-day average** Stock down 20% YTD, including the day's moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nL4N42A0CZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","IBX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640299960","title":"Imagion Biosystems - Receives FDA Ind Clearance for Magsense Her2 Imaging Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2640299960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640299960?lang=en_us&edition=fundamental","pubTime":"2026-06-02 07:05","pubTimestamp":1780355110,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nTUE2ZTGS0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IBX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625023998","title":"BRIEF-Imagion Biosystems Receives A$300,000 Additional Funding Under Mercer Street Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2625023998","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625023998?lang=en_us&edition=fundamental","pubTime":"2026-04-08 09:26","pubTimestamp":1775611587,"startTime":"0","endTime":"0","summary":"BRIEF-Imagion Biosystems Receives A$300,000 Additional Funding Under Mercer Street Agreement April 8 (Reuters) - Imagion Biosystems Ltd IBX.AX:RECEIVES A$300,000 ADDITIONAL FUNDING UNDER MERCER STREET AGREEMENTFurther company coverage: IBX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nFWN40Q1BY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBX.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608580538","title":"Imagion Biosystems Submits IND Application to FDA for MagSense HER2 Imaging Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2608580538","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608580538?lang=en_us&edition=fundamental","pubTime":"2026-02-04 00:30","pubTimestamp":1770136218,"startTime":"0","endTime":"0","summary":"Imagion Biosystems Ltd. has submitted an Investigational New Drug  application to the U.S. Food and Drug Administration  for its MagSense HER2 targeted imaging agent. The company plans to initiate a Phase 2 clinical trial to evaluate the imaging agent for detecting nodal metastases in HER2-positive breast cancer patients, pending FDA approval. Enrollment for the trial could begin as early as the first quarter of 2026, based on historical FDA review timelines. Imagion Biosystems has engaged all necessary strategic trial partners and is advancing logistical preparations in compliance with Good Clinical Practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imagion Biosystems Ltd. published the original content used to generate this ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL3fhmTg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","IBX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608805855","title":"Medical-Imaging Company Imagion Biosystems Lodges Ind With FDA for Phase 2 Trial of Magsense® Her2 Targeted Imaging Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2608805855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608805855?lang=en_us&edition=fundamental","pubTime":"2026-02-04 00:30","pubTimestamp":1770136200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUA84DDZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IBX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608058008","title":"Imagion Biosystems Ltd - Enrollment for Phase 2 Trial Could Begin Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2608058008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608058008?lang=en_us&edition=fundamental","pubTime":"2026-02-04 00:30","pubTimestamp":1770136200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUA84DDZD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBX.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}